Emilio Clementi

Dr Clementi is Full Professor of Pharmacology and Director of the Clinical Pharmacology Unit of the National Health System at the University of Milano, Italy, since 2005, Secretary general of IUPHAR (International Union of Basic and Clinical Pharmacology), and member of the Pharmacovigilance Risk Assessment Committee, the European Medicines Agency. He was previously Reader in Pharmacology at the University of Catanzaro, Italy (1992-1996), Research Fellow at the University College London (1996-1999) and Associate Professor of Pharmacology at the University of Calabria, Italy (1999-2005). He earned his MD degree at the University of Milano (1988) and his PhD in Experimental Pharmacotherapy at the University of Brescia (Italy) (1994). He has published more than 400 papers (h index 62) focused on the pathophysiology of nitric oxide and its relevance in therapeutic perspective, which led him to investigate its role as a therapeutic in clinical studies on Duchenne Muscular Dystrophy. The involvement in clinical pharmacology has grown significantly since 2005 with the direction of a Clinical Pharmacology Unit leading him to studies in pharmacokinetics and pharmacogenetics with a specific interest in paediatric patients, also running a pharmacovigilance programme on them sponsored by the Italian Medicines Agency.

He is involved in editorial activity, presently the Editor-in-Chief of Pharmacological Research and Pharmacological Research – Modern Chinese Medicine